The Anti-Breast Cancer Potential of Bis-Isatin Scaffolds.

Current Topics in Medicinal Chemistry
Hua Guo, Quan-Ping Diao

Abstract

To develop novel anti-breast cancer agents and discuss the structure-activity relationship of bis-isatin scaffolds. Breast cancer is the most common invasive cancer and the second leading cause of cancer death in women after lung cancer. Bis-isatin scaffolds possess potential anti-breast cancer activity, and some of them such as Indirubin could induce cancer cells apoptosis via multiply mechanisms. The primary objective of this study was to evaluate the potential of bis-isatin scaffolds with alkyl/ether linkers between the two isatin moieties against different human breast cancer cell lines including MCF-7, AU565, MDA-MB-231, MDA-MB-435 and MDA-MB-468 cells. The synthesized bis-isatin scaffolds with alkyl/ether linker between the two isatin moieties were evaluated for their in vitro activity against MCF-7, AU565, MDA-MB-231, MDA-MB-435, and MDA-MB-468 human breast cancer cell lines by MTT assay. All the synthesized compounds (IC50: 38.3-197.6 µM) possess considerable activity against MCF-7, AU565, MDA-MB-231, MDA-MB-435, and MDA-MB-468 human breast cancer cell lines, and the most potent compound 4e (IC50: 38.3-63.5 µM) was no inferior to Cisplatin (IC50: 20.1-38.6 μM) against the five tested human breast cancer cell lines. All ...Continue Reading

References

Oct 16, 2008·Anti-cancer Agents in Medicinal Chemistry·M K Hadden, B S J Blagg
Aug 7, 2013·Hematology/oncology Clinics of North America·Michael J Hassett, Elena B Elkin
Nov 2, 2013·European Journal of Medicinal Chemistry·Chengyuan LiangJing Gao
Feb 18, 2016·Bioorganic & Medicinal Chemistry Letters·Nikolai M EvdokimovAlexander Kornienko
Mar 25, 2016·Journal of Medicinal Chemistry·Tony FröhlichSvetlana B Tsogoeva
Oct 4, 2017·CA: a Cancer Journal for Clinicians·Carol E DeSantisAhmedin Jemal
Feb 24, 2018·Current Topics in Medicinal Chemistry·Qing-Cheng RenFeng Zhao
Oct 17, 2018·Drug Design, Development and Therapy·Lihong ChenJifen Hu
Jul 17, 2019·Current Pharmaceutical Design·Aida Raigon-PonferradaJosé Cruz-Mañas
Aug 7, 2019·Current Topics in Medicinal Chemistry·Leonel Montealegre-SánchezEliécer Jiménez-Charris
Dec 25, 2019·Seminars in Cancer Biology·Muhammad AfzalFiroz Anwar
Jan 22, 2020·Archiv der Pharmazie·Zhen DingCheng Zeng
Jan 28, 2020·Archiv der Pharmazie·Ya-Zhou ZhangZhi Xu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Related Papers

International Journal of Biological Sciences
Yi-Sheng SunHan-Ping Zhu
Italian Journal of Anatomy and Embryology = Archivio Italiano Di Anatomia Ed Embriologia
Vanessa NicolinRoberto Valentini
Acta Informatica Medica : AIM : Journal of the Society for Medical Informatics of Bosnia & Herzegovina : časopis Društva Za Medicinsku Informatiku BiH
Wahyu WidowatiMawar Subangkit
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
Sait Murat DoganSafiye Aktas
© 2021 Meta ULC. All rights reserved